Study Guide for Pharmacology - Elsevier eBook on VitalSource, 10th Edition

Section I: Introduction to Pharmacology
1.The Nursing Process and Patient-Centered Care
2.Drug Development and Ethical Considerations
3.Pharmacokinetics and Pharmacodynamics
4.Pharmacogenetics
5.Complementary and Alternative Therapies
6.Pediatric Considerations
7.Older Adult Considerations
8.Drugs in Substance Use Disorder
Section II: Pharmacotherapy and Drug Administration
9.Safety and Quality
10.Drug Administration
11.Drug Calculations
Section III: Maintenance of Homeostasis
12.Fluid Volume and Electrolytes
13.Vitamin and Mineral Replacement
14.Nutritional Support
Section IV: Autonomic Nervous System Drugs
15.Adrenergic Agonists and Antagonists
16.Cholinergic Agonists and Antagonists
Section V: Central and Peripheral Nervous System Drugs
17.Stimulants
18.Depressants
19.Antiseizure Drugs
20.Drugs for Parkinsonism and Alzheimer’s Disease
21.Drugs for Neuromuscular Disorders and Muscle Spasms
Section VI: Mental and Behavioral Health Drugs
22.Antipsychotics and Anxiolytics
23.Antidepressants and Mood Stabilizers
Section VII: Pain and Inflammation Management Drugs
24.Antiinflammatories
25.Analgesics
Section VIII: Antimicrobial Drugs
26.Antibacterials
1.Section A: Penicillins and Cephalosporins
2.Section B: Macrolides and Tetracyclines
3.Section C: Aminoglycosides and Fluoroquinolones
4.Section D: Sulfonamides and Metronidazole
27.Antituberculars, Antifungals, and Antivirals
28.Antimalarials, Anthelmintics, and Peptides
Section IX: Immunologic Drugs
29.HIV- and AIDS-Related Drugs
30.Transplant Drugs
31.Vaccines
Section X: Antineoplastics and Biologic Response Modifiers
32.Anticancer Drugs
33.Targeted Therapies to Treat Cancer
34.Biologic Response Modifiers
Section XI: Respiratory Drugs
35.Upper Respiratory Disorders
36.Lower Respiratory Disorders
Section XII: Cardiovascular Drugs
37.Cardiac Glycosides, Antianginals, and Antidysrhythmics
38.Diuretics
39.Antihypertensives
1.Section A: Beta Blockers
2.Section B: Alpha Blockers
3.Section C: Drugs Affecting RAAS
4.Section D: Calcium Channel Blockers
40.Anticoagulants, Antiplatelets, and Thrombolytics
41.Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow
Section XIII: Gastrointestinal Drugs
42.Gastrointestinal Tract Disorders
43.Antiulcer Drugs
Section XIV: Eye, Ear, and Skin Drugs 
44.Eye and Ear Disorders
45.Dermatologic Disorders
Section XV: Endocrine Drugs
46.Pituitary, Thyroid, Parathyroid, and Adrenal Disorders
47.Antidiabetics
Section XVI: Renal and Urologic Drugs
48.Urinary Disorders
Section XVII: Reproductive and Gender-Related Drugs
49.Pregnancy and Preterm Labor
50.Labor, Delivery, and Postpartum
51.Neonatal and Newborn
52.Women’s Reproductive Health
53.Men’s Health and Reproductive Disorders
54.Sexually Transmitted Infections
Section XVIII: Emergency Drugs
55.Adult and Pediatric Emergency Drugs
Answer Key

Linda E. McCuistion, PhD, MSN, RN, Professor (Ret.), University of Holy Cross, New Orleans, Louisiana, USA, Kathleen Vuljoin DiMaggio, MSN, RN, Professor Emerita, University of Holy Cross, New Orleans, Louisiana, USA, Mary B. Winton, PhD, MSN, RN, Associate Professor, Tarleton State University, Stephenville, Texas, USA and Jennifer J. Yeager, PhD, MSN, RN, Associate Professor, Tarleton State University, Stephenville, Texas, USA